BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 36408807)

  • 21. Therapeutic plasma exchange in antisynthetase syndrome with severe interstitial lung disease.
    Omotoso BA; Ogden MI; Balogun RA
    J Clin Apher; 2015 Dec; 30(6):375-9. PubMed ID: 25727180
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The prognostic role of C-reactive protein to albumin ratio and anti-MDA5 antibody-positive in idiopathic inflammatory myopathy: a retrospective study.
    Zhou P; Shen Q; Zhou S; Ouyang X; Guo T; Song M; Guo W; Zhang Y; Peng H
    Sci Rep; 2023 Mar; 13(1):3863. PubMed ID: 36890164
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A Comprehensive Overview on Myositis-Specific Antibodies: New and Old Biomarkers in Idiopathic Inflammatory Myopathy.
    Satoh M; Tanaka S; Ceribelli A; Calise SJ; Chan EK
    Clin Rev Allergy Immunol; 2017 Feb; 52(1):1-19. PubMed ID: 26424665
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Predictive Features and Clinical Presentation of Interstitial Lung Disease in Inflammatory Myositis.
    Vojinovic T; Cavazzana I; Ceruti P; Fredi M; Modina D; Berlendis M; Franceschini F
    Clin Rev Allergy Immunol; 2021 Feb; 60(1):87-94. PubMed ID: 33141387
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The significance of myositis autoantibodies in idiopathic inflammatory myopathy concomitant with interstitial lung disease.
    Huang HL; Lin WC; Lin PY; Weng MY; Sun YT
    Neurol Sci; 2021 Jul; 42(7):2855-2864. PubMed ID: 33211209
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Biomarkers and Autoantibodies of Interstitial Lung Disease with Idiopathic Inflammatory Myopathies.
    Yoshifuji H
    Clin Med Insights Circ Respir Pulm Med; 2015; 9(Suppl 1):141-6. PubMed ID: 27081322
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Differential clinical features of patients with clinically amyopathic dermatomyositis who have circulating anti-MDA5 autoantibodies with or without myositis-associated autoantibodies.
    Yamaguchi K; Yamaguchi A; Kashiwagi C; Sawada Y; Taguchi K; Umetsu K; Oshima K; Uchida M; Suzuki M; Kono S; Takemura M; Masubuchi H; Kitahara S; Hara K; Maeno T; Motegi SI; Muro Y; Sakairi T; Hisada T; Kurabayashi M
    Respir Med; 2018 Jul; 140():1-5. PubMed ID: 29957268
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Myositis-associated interstitial lung disease.
    Vu TTT; Brown KK; Solomon JJ
    Curr Opin Pulm Med; 2023 Sep; 29(5):427-435. PubMed ID: 37435671
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical Significance of Serum Chitotriosidase Level in Anti-MDA5 Antibody-positive Dermatomyositis-associated Interstitial Lung Disease.
    Fujisawa T; Hozumi H; Yasui H; Suzuki Y; Karayama M; Furuhashi K; Enomoto N; Nakamura Y; Inui N; Suda T
    J Rheumatol; 2019 Aug; 46(8):935-942. PubMed ID: 31092718
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Rituximab in the treatment of anti-MDA5 dermatomyositis-associated interstitial lung disease: a case-based literature review.
    Nascimento J; Tenazinha C; Campanilho-Marques R; Cordeiro I; Salgado S
    ARP Rheumatol; 2022; 1(2):168-173. PubMed ID: 35810375
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A case of clinically amyopathic dermatomyositis that was refractory to intensive immunosuppressive therapy including tofacitinib, but successfully treated with plasma exchange therapy.
    Hiraoka D; Ishizaki J; Horie K; Matsumoto T; Suemori K; Takenaka K; Hasegawa H
    Mod Rheumatol Case Rep; 2022 Jun; 6(2):194-198. PubMed ID: 34984465
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A systematic review of adult-onset clinically amyopathic dermatomyositis (dermatomyositis siné myositis): a missing link within the spectrum of the idiopathic inflammatory myopathies.
    Gerami P; Schope JM; McDonald L; Walling HW; Sontheimer RD
    J Am Acad Dermatol; 2006 Apr; 54(4):597-613. PubMed ID: 16546580
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Myositis-specific autoantibodies and their clinical associations in idiopathic inflammatory myopathies: results from a cohort from China.
    Wen L; Chen X; Cheng Q; Nie L; Xu J; Yan T; Zhang X; Yang H; Sun W; Liu L; Xue J; Du Y
    Clin Rheumatol; 2022 Nov; 41(11):3419-3427. PubMed ID: 35859245
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Efficiency of Therapeutic Plasma-Exchange in Acute Interstitial Lung Disease, Associated With Polymyositis/Dermatomyositis Resistant to Glucocorticoids and Immunosuppressive Drugs: A Retrospective Study.
    Ning Y; Yang G; Sun Y; Chen S; Liu Y; Shi G
    Front Med (Lausanne); 2019; 6():239. PubMed ID: 31781564
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Interstitial lung disease with and without progressive fibrosing phenotype in patients with idiopathic inflammatory myopathies: data from a large multicentric cohort.
    Zanatta E; Cocconcelli E; Castelli G; Giraudo C; Fraia AS; De Zorzi E; Gatto M; Ienna L; Treppo E; Malandrino D; Cereser L; Emmi G; Giannelli F; Bellani S; Martini A; Moccaldi B; Ghirardello A; Avouac J; Quartuccio L; Allanore Y; Doria A; Spagnolo P; Balestro E; Iaccarino L
    RMD Open; 2023 Aug; 9(3):. PubMed ID: 37541742
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Interstitial lung disease and idiopathic inflammatory myopathies: progress and pitfalls.
    Labirua A; Lundberg IE
    Curr Opin Rheumatol; 2010 Nov; 22(6):633-8. PubMed ID: 20827201
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Treatment of antisynthetase-associated interstitial lung disease with tacrolimus.
    Wilkes MR; Sereika SM; Fertig N; Lucas MR; Oddis CV
    Arthritis Rheum; 2005 Aug; 52(8):2439-46. PubMed ID: 16052580
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The role of therapeutic plasma exchange in clinically amyopathic dermatomyositis with MDA-5 antibody: A case report and review of the literature.
    Fine A; Karp JK; Peedin AR
    J Clin Apher; 2020 Sep; 35(5):483-487. PubMed ID: 33617011
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Serum levels of galectin-3 in idiopathic inflammatory myopathies: a potential biomarker of disease activity.
    Watanabe E; Kato K; Gono T; Chiba E; Terai C; Kotake S
    Rheumatology (Oxford); 2021 Jan; 60(1):322-332. PubMed ID: 32770187
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Idiopathic inflammatory myopathies and the lung.
    Lega JC; Reynaud Q; Belot A; Fabien N; Durieu I; Cottin V
    Eur Respir Rev; 2015 Jun; 24(136):216-38. PubMed ID: 26028634
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.